Concepedia

Reshma Kewalramani

RK

23

Publications

3.6K

Citations

21

H-Index

1997

Active since

Affiliations

Amgen (United States)(Current)

Brigham and Women's Hospital

Harvard University

Colorado Kidney Care

University of Glasgow

Reshma Kewalramani is an author at Amgen (United States) specializing in medicine, nephrology, and chronic kidney disease.

Top concepts

Publications per year

1997–2017

23

Publications

23

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

Marc A. Pfeffer, Emmanuel A. Burdmann, Chao Yin Chen et al. · New England Journal of Medicine · 2009 · 2K citations · Full text

Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism

Geoffrey A. Block, David A. Bushinsky, Sunfa Cheng et al. · JAMA · 2017 · 297 citations · Full text

Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism

Geoffrey A. Block, David A. Bushinsky, John Cunningham et al. · JAMA · 2017 · 150 citations · Full text

, , +13

Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference

Colin Baigent, William G. Herrington, Josef Coresh et al. · Kidney International · 2017 · 145 citations · Full text

Association Between Cardiac Biomarkers and the Development of ESRD in Patients With Type 2 Diabetes Mellitus, Anemia, and CKD

Akshay S. Desai, Robert D. Toto, Petr Jarolı́m et al. · American Journal of Kidney Diseases · 2011 · 142 citations

, , +8

Rows per page

1–5 of 23